About: Clinical utility of the Revised International Staging System in unselected patients with newly diagnosed and relapsed multiple myeloma

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Clinical utility of the Revised International Staging System in unselected patients with newly diagnosed and relapsed multiple myeloma Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 17 February 2017

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2017 (ast) наукова стаття, опублікована в лютому 2017 (uk) scientific article published on 17 February 2017 (en) مقالة علمية نشرت في 17 فبراير 2017 (ar)
publication date	wds:Q37744801-3F6693DC-6666-4F54-B093-5562425C31F3
publication date	2017-02-17 00:00:00Z (xsd:dateTime)
exact match	wds:Q37744801-3C37FFD7-A6DC-4569-9F80-38043F14DEE2
exact match	https://scigraph.springernature.com/pub.10.1038/bcj.2017.13
cites work	wds:Q37744801-0480408E-FC54-47E5-87E5-5CA91F24D769 wds:Q37744801-0A3791FD-4E39-40C4-8486-BAD5E0B67962 wds:Q37744801-0B8A8927-3FDF-4894-8FD1-6008C33249EE wds:Q37744801-25D0C119-373E-4316-8B17-C50FD05F34E3 wds:Q37744801-28F97124-2D49-4709-B624-479CCA0B9075 wds:Q37744801-2C32E1DD-B964-4705-BD88-2306842847C7 wds:Q37744801-2E762A45-ED72-40F8-BE6F-FB84D4810C68 wds:Q37744801-30E3B96D-41DE-4718-B263-C8D283F76FC3 wds:Q37744801-352EBDB6-5647-4258-8D8C-35B2BE539014 wds:Q37744801-3C17A1DA-4B63-4907-8EFC-FDDC30B744C3 wds:Q37744801-44187335-F0D4-46BE-8515-931E76360E17 wds:Q37744801-5D5EA238-7353-41E8-BD5A-A4FCD50EE5EF wds:Q37744801-69F847DD-E678-4C1E-A7A7-A91A236095BC wds:Q37744801-79C462F1-1BF0-49D1-83CC-BD71E8EF288E wds:Q37744801-7BFADB4E-9742-473F-84DE-3644F4EC0196 wds:Q37744801-894148D7-978A-42D0-A650-8A5D260C1A38 wds:Q37744801-91C3B840-2B23-4835-9DFB-D624B53B0CC0 wds:Q37744801-979B502A-7FDD-4734-9F78-6C9C25FAA7EB wds:Q37744801-A4E5EE71-C77C-422D-A3C9-3E0E91110A74 wds:Q37744801-AB28C116-54F2-4B9D-98F4-58F3C5188929 wds:Q37744801-CB8C49BD-BE97-4B75-AC72-0B4778B1CF0F wds:Q37744801-CD8379EC-7134-451E-B7E0-7CA4AB912B0D wds:Q37744801-E2D6E8E5-4A2B-498A-AB78-DBC4463A3D90 wds:Q37744801-FDBC608F-AFF2-4A5F-B41F-E3B11D8BED7B wds:Q37744801-FFF7A329-549F-456C-9936-BAA4FF24F494
cites work	Are randomized clinical trials good for us (in the short term)? Evidence for a "trial effect". International Myeloma Working Group molecular classification of multiple myeloma: spotlight review. Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study Participation in cancer clinical trials: race-, sex-, and age-based disparities International staging system for multiple myeloma Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients. Ethical issues in the design and conduct of randomised controlled trials. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1. Beta 2-microglobulin: its significance and clinical usefulness Generalizability of cancer clinical trial results: prognostic differences between participants and nonparticipants. Comparison of survival outcomes among cancer patients treated in and out of clinical trials A prospective analysis of the influence of older age on physician and patient decision-making when considering enrollment in breast cancer clinical trials (SWOG S0316). High serum lactate dehydrogenase level as a marker for drug resistance and short survival in multiple myeloma Prognostic significance of copy-number alterations in multiple myeloma Myeloma today: Disease definitions and treatment advances High serum lactate dehydrogenase adds prognostic value to the international myeloma staging system even in the era of novel agents Combination of international scoring system 3, high lactate dehydrogenase, and t(4;14) and/or del(17p) identifies patients with multiple myeloma (MM) treated with front-line autologous stem-cell transplantation at high risk of early MM progression-r Systematic review to determine whether participation in a trial influences outcome Interpretation of cytogenetic results in multiple myeloma for clinical practice New investigational drugs with single-agent activity in multiple myeloma Comparison of clinical trial versus non-clinical trial treatment outcomes of childhood acute lymphoblastic leukemia using comparable regimens Factors influencing enrollment in clinical trials for cancer treatment
author name string	wds:Q37744801-0B75B84E-3A2F-4B2B-B086-AE0F1A21BEDC wds:Q37744801-104AD901-6458-4D9B-90B5-E7FAEF3162DA wds:Q37744801-2A629488-DE0B-4886-9467-467BD2F8870C wds:Q37744801-2D34858C-B78B-4535-B1A1-3BDB181FC4FF wds:Q37744801-2EED1F83-FB2A-488F-B6D9-50CE3AA662DA wds:Q37744801-370BDA20-6299-4D3C-880F-1519C64DBFA4 wds:Q37744801-39F6C1A0-80E8-4F8E-A844-F7EC29F88A59 wds:Q37744801-BF7B9652-7B44-4475-9A32-8BB627B3D678 wds:Q37744801-C9C36174-AB5A-4F45-98FC-D3F470B25350 wds:Q37744801-D9EC64B4-A283-4CE0-8A33-5174EF7D4A39 wds:Q37744801-F23CDAAF-F5B4-40F6-898A-73644C54712C
author name string	Y Lin P Kapoor S J Russell N Tandon B LaPlant S K Kumar S R Hayman S R Zeldenrust Y L Hwa A L Fonder A Pettinger
rdfs:label	Clinical utility of the Revised International Staging System in unselected patients with newly diagnosed and relapsed multiple myeloma (en) Clinical utility of the Revised International Staging System in unselected patients with newly diagnosed and relapsed multiple myeloma (ast) Clinical utility of the Revised International Staging System in unselected patients with newly diagnosed and relapsed multiple myeloma. (nl)
skos:prefLabel	Clinical utility of the Revised International Staging System in unselected patients with newly diagnosed and relapsed multiple myeloma (en) Clinical utility of the Revised International Staging System in unselected patients with newly diagnosed and relapsed multiple myeloma (ast) Clinical utility of the Revised International Staging System in unselected patients with newly diagnosed and relapsed multiple myeloma. (nl)
name	Clinical utility of the Revised International Staging System in unselected patients with newly diagnosed and relapsed multiple myeloma (en)

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software